The 340B Drug Pricing Program was created in 1992 by the federal government and requires drug manufacturers to provide significant discounts for outpatient drugs to eligible healthcare organizations, also known as “Covered Entities.” The program is designed to provide financial benefits to Covered Entities that serve low-income and uninsured patients, enabling expansion of healthcare services to better serve their communities and to improve access to more affordable medications for their low-income and uninsured patients.
Get more info at the Health Resources & Services Administration Website
Apexus
Apexus is the nation's leader in creating reliable health care solutions by enhancing access to medications and improving patient care. Apexus achieves these outcomes through innovative ambulatory pharmacy solutions and support of compliant 340B programs.
Gain valuable information through 340B Prime Vendor Program (PVP) managed by Apexus™ which provides 340B education and supports program integrity through technical assistance.
Access valuable 340B educational resources through 340B PVP managed by Apexus™
340B Health
340B Health is a nonprofit membership organization of more than 1,400 public and private non-profit hospitals and health systems throughout the U.S. that participate in the 340B drug pricing program. They are the leading advocate and resource for those hospitals who serve their communities through participation in 340B.
SUNRx is a proud corporate partner of 340B Health.
Stay informed about 340B advocacy and learn more about 340B Health